Go Pro

Santen Pharmaceutical (SNPHY) Short Interest Ratio & Short Volume

Santen Pharmaceutical logo
$10.92 -0.76 (-6.47%)
As of 03:20 PM Eastern

Santen Pharmaceutical Short Interest Overview

As of July 31, 2026, Santen Pharmaceutical (SNPHY) had a short interest of 3,813 shares sold short, representing 0.00% of the public float. This marks a 90.27% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.5, meaning it would take 0.5 days of the average trading volume of 9,487 shares to cover all short positions.

Current Short Interest
3,813 shares
Previous Short Interest
2,004 shares
Change Vs. Previous Month
90.27%
Dollar Volume Sold Short
$45.09 thousand
Short Interest Ratio
0.5 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
322,290,000 shares
Short Percent of Float
0.00%
Today's Trading Volume
1,324 shares
Average Trading Volume
9,487 shares
Today's Volume Vs. Average
14%
Short Selling Santen Pharmaceutical?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Santen Pharmaceutical and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

SNPHY Short Interest Over Time

SNPHY Days to Cover Over Time

SNPHY Percentage of Float Shorted Over Time

Santen Pharmaceutical Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20263,813 shares $45.09 thousand +90.3%0.0%0.54 $11.83
7/15/20262,004 shares $25.99 thousand +235.7%0.0%0.2 $12.97
6/30/2026597 shares $8.03 thousand -60.3%0.0%0.19 $13.45
6/15/20261,503 shares $17.74 thousand -87.7%0.0%0.23 $11.80
5/29/202612,174 shares $146.45 thousand +9.6%0.0%3.34 $12.03
5/15/202611,113 shares $130.43 thousand +314.4%0.0%0.79 $11.74
4/30/20262,682 shares $28.63 thousand -60.7%0.0%0.03 $10.68
4/15/20266,831 shares $79.05 thousand +1,554.0%0.0%0.35 $11.57
3/31/2026413 shares $4.59 thousand -94.9%0.0%0.05 $11.12
3/13/20268,087 shares $82.00 thousand +78.9%0.0%1.01 $10.14
2/27/20264,520 shares $50.17 thousand -97.6%0.0%0.2 $11.10
2/13/2026185,690 shares $2.07 million +15,335.6%0.1%4 $11.17
1/30/20261,203 shares $13.58 thousand +4.8%0.0%0.03 $11.29
1/15/20261,148 shares $12.89 thousand -3.5%0.0%0.06 $11.23
12/31/20251,189 shares $12.25 thousand -68.7%0.0%0.03 $10.30
12/15/20254,712 shares $47.87 thousand -82.6%N/A0.36 $10.16
11/28/202527,049 shares $277.25 thousand +1,721.5%N/A0.47 $10.25
11/14/20251,485 shares $15.30 thousand -48.6%N/A0.18 $10.31
10/31/20252,888 shares $28.79 thousand +182.3%N/A0.49 $9.97
10/15/20251,000 shares $10.21 thousand +100.0%N/A0 $10.21
9/30/2025500 shares $5.64 thousand -28.6%N/A0.1 $11.27
9/15/2025700 shares $7.69 thousand -12.5%N/A0.1 $10.98
8/31/2025800 shares $8.47 thousand +700.0%N/A0.1 $10.59
8/15/2025100 shares $1.06 thousand -93.3%N/A0 $10.63
7/31/20251,500 shares $16.54 thousand -21.1%N/A0.1 $11.03
7/15/20251,900 shares $22.04 thousand -29.6%N/A0.8 $11.60
6/30/20252,700 shares $31.39 thousand +2,600.0%N/A0.5 $11.63
6/15/2025100 shares $1.17 thousand -93.3%N/A0 $11.73
5/31/20251,500 shares $16.50 thousand -76.9%N/A0.3 $11.00
5/15/20256,500 shares $69.62 thousand +6,400.0%N/A1.2 $10.71
4/30/2025100 shares $1.03 thousand -98.9%N/A0 $10.29
4/15/20259,400 shares $89.34 thousand +2,250.0%N/A1 $9.50
3/31/2025400 shares $3.79 thousand -83.3%N/A0 $9.47
3/15/20252,400 shares $23.59 thousand -55.6%N/A0.4 $9.83
2/28/20255,400 shares $49.98 thousand -50.9%N/A0.5 $9.26
2/15/202511,000 shares $104.83 thousand +32.5%N/A0.6 $9.53
1/31/20258,300 shares $84.99 thousand +295.2%N/A0.1 $10.24
1/15/20252,100 shares $20.41 thousand +110.0%N/A0.2 $9.72
12/31/20241,000 shares $10.12 thousand No ChangeN/A0 $10.12
11/30/2024100 shares $1.06 thousand No ChangeN/A0 $10.61
Why major institutions are piling into this digital asset now (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
10/31/2024100 shares $1.18 thousand -85.7%N/A0 $11.84
10/15/2024700 shares $8.44 thousand -12.5%N/A0.3 $12.06
9/30/2024800 shares $10.12 thousand -57.9%N/A0.1 $12.66
9/15/20241,900 shares $24.35 thousand -17.4%N/A0.5 $12.82
8/31/20242,300 shares $28.51 thousand +4.6%N/A1 $12.40
8/15/20242,200 shares $26.55 thousand +15.8%N/A0.1 $12.07
7/31/20241,900 shares $22.33 thousand -24.0%N/A0 $11.75
7/15/20242,500 shares $28.18 thousand -3.9%N/A1.9 $11.27
6/30/20242,600 shares $26.52 thousand -10.3%N/A0.2 $10.20
6/15/20242,900 shares $29.72 thousand +383.3%N/A0.8 $10.25
5/31/2024600 shares $6.16 thousand No ChangeN/A0.3 $10.27
4/30/2024100 shares $994.00 No ChangeN/A0 $9.94
4/15/2024100 shares $912.00 No ChangeN/A0 $9.12
3/31/2024100 shares $975.00 No ChangeN/A0.1 $9.75
3/15/2024100 shares $982.42 -99.5%N/A0 $9.82
2/29/202420,800 shares $204.46 thousand +20,700.0%N/A0.7 $9.83
2/15/2024100 shares $1.00 thousand No ChangeN/A0 $10.01
1/15/2024100 shares $1.01 thousand No ChangeN/A0.1 $10.14
11/30/2023900 shares $8.60 thousand +80.0%N/A0.4 $9.55
11/15/2023500 shares $4.49 thousand +400.0%N/A0.1 $8.98
10/31/2023100 shares $868.50 -85.7%N/A0 $8.69
10/15/2023700 shares $6.20 thousand -41.7%N/A0.3 $8.86
9/30/20231,200 shares $10.94 thousand -64.7%N/A0.3 $9.12
9/15/20233,400 shares $32.88 thousand -30.6%N/A2.1 $9.67
8/31/20234,900 shares $45.30 thousand +36.1%N/A1.5 $9.25
8/15/20233,600 shares $33.59 thousand -52.6%N/A0.4 $9.33
7/31/20237,600 shares $65.66 thousand +216.7%N/A1.4 $8.64
7/15/20232,400 shares $20.04 thousand +242.9%N/A0.3 $8.35
6/30/2023700 shares $5.91 thousand +16.7%N/A0 $8.44
6/15/2023600 shares $5.10 thousand +100.0%N/A0.1 $8.50
5/31/2023300 shares $2.74 thousand -25.0%N/A0.2 $9.14
5/15/2023400 shares $3.62 thousand No ChangeN/A0.2 $9.06
4/15/2023400 shares $3.30 thousand +100.0%N/A0.1 $8.24
3/31/2023200 shares $1.69 thousand -60.0%N/A0 $8.47
3/15/2023500 shares $3.81 thousand No ChangeN/A0.1 $7.62
2/15/2023100 shares $739.00 -90.0%N/A0 $7.39
1/31/20231,000 shares $7.71 thousand No ChangeN/A0.2 $7.71
12/30/2022700 shares $5.62 thousand -58.8%N/A0.1 $8.04
12/15/20221,700 shares $13.64 thousand -74.6%N/A0.2 $8.03
11/30/20226,700 shares $53.60 thousand +86.1%N/A0.4 $8.00
11/15/20223,600 shares $27.47 thousand +12.5%N/A0.1 $7.63
10/31/20223,200 shares $21.84 thousand -94.0%N/A0.1 $6.83
10/15/202253,100 shares $348.34 thousand +517.4%N/A0.9 $6.56
9/30/20228,600 shares $58.22 thousand +207.1%N/A0.1 $6.77
9/15/20222,800 shares $18.76 thousand -85.6%N/A0 $6.70
8/31/202219,500 shares $139.23 thousand +236.2%N/A0.3 $7.14
8/15/20225,800 shares $45.40 thousand +5,700.0%N/A0.2 $7.83
7/31/2022100 shares $801.50 No ChangeN/A0 $8.02
6/15/2022400 shares $2.92 thousand -90.9%N/A0 $7.29
5/31/20224,400 shares $35.31 thousand -63.3%N/A0 $8.03
Elon Musk’s Hushed FCC Filing. Sept 25th. (Ad)

Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel

Click here to see details on Elon Musk's newest AI filing
5/15/202212,000 shares $95.52 thousand +823.1%N/A0 $7.96
4/30/20221,300 shares $10.52 thousand -38.1%N/A0 $8.09
4/15/20222,100 shares $18.27 thousand -92.0%N/A0 $8.70
3/31/202226,300 shares $262.47 thousand +87.9%N/A0.3 $9.98
3/15/202214,000 shares $152.60 thousand -8.5%N/A0.1 $10.90
2/28/202215,300 shares $173.35 thousand -26.4%N/A0.1 $11.33
2/15/202220,800 shares $236.50 thousand +300.0%N/A0.1 $11.37
1/31/20225,200 shares $58.81 thousand +1,200.0%N/A0 $11.31
1/15/2022400 shares $4.86 thousand -98.2%N/A0 $12.16
12/31/202121,600 shares $262.98 thousand No ChangeN/A0.1 $12.18
11/30/20211,800 shares $23.67 thousand -85.9%N/A0 $13.15
11/15/202112,800 shares $178.41 thousand +17.4%N/A0.3 $13.94
10/29/202110,900 shares $153.69 thousand +10,800.0%N/A0.2 $14.10
10/15/2021100 shares $1.38 thousand -98.4%N/A0 $13.78
9/30/20216,400 shares $90.02 thousand +52.4%N/A0.2 $14.07
9/15/20214,200 shares $63.80 thousand -8.7%N/A0.2 $15.19

SNPHY Short Interest - Frequently Asked Questions

Short interest is the volume of Santen Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 3,813 shares of SNPHY short. 0.00% of Santen Pharmaceutical's shares are currently sold short. Learn More on Santen Pharmaceutical's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNPHY shares currently have a short interest ratio of 0.5. Learn More on Santen Pharmaceutical's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Santen Pharmaceutical's floating shares are currently sold short.

Santen Pharmaceutical saw a increase in short interest in July. As of July 31st, there was short interest totaling 3,813 shares, an increase of 90.3% from the previous total of 2,004 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Santen Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Santen Pharmaceutical: Shionogi & Co., Ltd. Unsponsored ADR (0.00%), Orion OYJ Unsponsored ADR (0.00%), Corcept Therapeutics Incorporated (10.96%), Recordati Industria Chimica E Farmaceutica S.P.A. (0.02%), Elanco Animal Health Incorporated (6.26%), Axsome Therapeutics, Inc. (7.41%), Dr. Reddy's Laboratories Ltd (2.92%), Crinetics Pharmaceuticals, Inc. (6.71%), Ono Pharmaceutical Co. (0.86%), Lantheus Holdings, Inc. (6.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling SNPHY is an investing strategy that aims to generate trading profit from Santen Pharmaceutical as its price is falling. SNPHY shares are trading down $0.76 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Santen Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPHY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPHY, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SNPHY:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for OTCMKTS:SNPHY is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners